methane has been researched along with rifamycins in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Foran, P; Majewski, M; McCallum, RW; Reddymasu, SC; Sostarich, S | 1 |
| Majewski, M; McCallum, RW | 1 |
| Hua, J; Hwang, L; Low, K; Morales, W; Pimentel, M; Zhu, A | 1 |
| Akopian, G; Coloma, E; Fernández, M; Kaufman, HS; Ortega, A; Petrone, P; Sarkisyan, G | 1 |
| Bartha, G; Boros, M; Erős, G; Garab, D; Ghyczy, M; Janovszky, Á; Kaszaki, J; Mohácsi, Á; Szabó, A; Szabó, G; Tuboly, E | 1 |
| Amichai, M; Chang, C; Chua, KS; DiBaise, J; Mirocha, J; Pimentel, M; Rao, S | 1 |
3 trial(s) available for methane and rifamycins
| Article | Year |
|---|---|
Efficacy of rifaximin, a nonabsorbed oral antibiotic, in the treatment of small intestinal bacterial overgrowth.
Topics: Adult; Aged; Aged, 80 and over; Anti-Infective Agents; Bacterial Infections; Breath Tests; Female; Gastrointestinal Agents; Gastrointestinal Diseases; Humans; Hydrogen; Intestine, Small; Male; Methane; Middle Aged; Rifamycins; Rifaximin; Treatment Outcome | 2007 |
Results of small intestinal bacterial overgrowth testing in irritable bowel syndrome patients: clinical profiles and effects of antibiotic trial.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Breath Tests; Cohort Studies; Female; Glucose; Humans; Intestine, Small; Irritable Bowel Syndrome; Male; Methane; Middle Aged; Proton Pumps; Rifamycins; Rifaximin | 2007 |
Antibiotic treatment of constipation-predominant irritable bowel syndrome.
Topics: Adult; Anti-Infective Agents; Breath Tests; Constipation; Female; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Male; Methane; Middle Aged; Neomycin; Rifamycins; Rifaximin | 2014 |
3 other study(ies) available for methane and rifamycins
| Article | Year |
|---|---|
A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test.
Topics: Adult; Aged; Anti-Bacterial Agents; Anti-Infective Agents; Breath Tests; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Irritable Bowel Syndrome; Male; Methane; Middle Aged; Neomycin; Retrospective Studies; Rifamycins; Rifaximin; Treatment Outcome | 2010 |
Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery.
Topics: Adult; Aged; Anti-Infective Agents; Bacteria; Breath Tests; Diagnosis, Differential; Digestive System Surgical Procedures; Female; Gastrointestinal Agents; Gastrointestinal Tract; Gram-Negative Bacteria; Helicobacter pylori; Humans; Hydrogen; Hydrogen-Ion Concentration; Intestine, Small; Irritable Bowel Syndrome; Logistic Models; Male; Methane; Middle Aged; Research Design; Retrospective Studies; Rifamycins; Rifaximin; Sample Size | 2011 |
Methane biogenesis during sodium azide-induced chemical hypoxia in rats.
Topics: Adenosine Triphosphate; Animals; Cell Hypoxia; Enzyme Inhibitors; Gastrointestinal Agents; Gastrointestinal Tract; Glycerylphosphorylcholine; Inflammation; Liver Circulation; Male; Methane; Microcirculation; Microscopy, Confocal; Microscopy, Video; Peroxidase; Photoacoustic Techniques; Rats; Rats, Sprague-Dawley; Rifamycins; Rifaximin; Sodium Azide; Xanthine Dehydrogenase | 2013 |